title: T-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and -II binding motifs.
abstract: The yellow fever vaccines (YF-17D-204 and 17DD) are considered to be among the safest vaccines and the presence of neutralizing antibodies is correlated with protection, although other immune effector mechanisms are known to be involved. T-cell responses are known to play an important role modulating antibody production and the killing of infected cells. However, little is known about the repertoire of T-cell responses elicited by the YF-17DD vaccine in humans. In this report, a library of 653 partially overlapping 15-mer peptides covering the envelope (Env) and nonstructural (NS) proteins 1 to 5 of the vaccine was utilized to perform a comprehensive analysis of the virus-specific CD4(+) and CD8(+) T-cell responses. The T-cell responses were screened ex-vivo by IFN-γ ELISPOT assays using blood samples from 220 YF-17DD vaccinees collected two months to four years after immunization. Each peptide was tested in 75 to 208 separate individuals of the cohort. The screening identified sixteen immunodominant antigens that elicited activation of circulating memory T-cells in 10% to 33% of the individuals. Biochemical in-vitro binding assays and immunogenetic and immunogenicity studies indicated that each of the sixteen immunogenic 15-mer peptides contained two or more partially overlapping epitopes that could bind with high affinity to molecules of different HLAs. The prevalence of the immunogenicity of a peptide in the cohort was correlated with the diversity of HLA-II alleles that they could bind. These findings suggest that overlapping of HLA binding motifs within a peptide enhances its T-cell immunogenicity and the prevalence of the response in the population. In summary, the results suggests that in addition to factors of the innate immunity, "promiscuous" T-cell antigens might contribute to the high efficacy of the yellow fever vaccines.
authors: Virology and Experimental Therapeutics Laboratory, Aggeu Magalhães Research Center, Fiocruz, Recife, Pernambuco, Brazil.
authors: Andréa Barbosa
authors: AB
authors: de Melo
authors: Eduardo J M
authors: EJ
authors: Nascimento
authors: Ulisses
authors: U
authors: Braga-Neto
authors: Rafael
authors: R
authors: Dhalia
authors: Ana Maria
authors: AM
authors: Silva
authors: Mathias
authors: M
authors: Oelke
authors: Jonathan P
authors: JP
authors: Schneck
authors: John
authors: J
authors: Sidney
authors: Alessandro
authors: A
authors: Sette
authors: Silvia M L
authors: SM
authors: Montenegro
authors: Ernesto T A
authors: ET
authors: Marques
mesh_terms: D058501:Enzyme-Linked Immunospot Assay; D018984:Epitopes, T-Lymphocyte / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D006801:Humans; D007156:Immunologic Memory; D007371:Interferon-gamma / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology*; D022341:Yellow Fever Vaccine / Q000008:administration & dosage / Q000276:immunology*
chemical_list: D018984:Epitopes, T-Lymphocyte; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II; D022341:Yellow Fever Vaccine; D007371:Interferon-gamma
references: Eur J Immunol. 1989 Dec;19(12):2237-42
references: 2481588
references: J Immunol. 2010 Mar 1;184(5):2492-503
references: 20139279
references: Nat Rev Immunol. 2004 Aug;4(8):595-602
references: 15286726
references: Expert Rev Vaccines. 2005 Aug;4(4):553-74
references: 16117712
references: Virology. 2002 Feb 1;293(1):151-63
references: 11853408
references: Immunome Res. 2008 Jan 25;4:2
references: 18221540
references: Curr Protoc Immunol. 2001 May;Chapter 18:Unit 18.3
references: 18432745
references: Bull World Health Organ. 1981;59(6):895-900
references: 6978196
references: J Immunol. 1998 Apr 1;160(7):3363-73
references: 9531296
references: Mol Immunol. 2004 Feb;40(14-15):1047-55
references: 15036909
references: Am J Trop Med Hyg. 2011 Oct;85(4):739-47
references: 21976581
references: J Exp Med. 2008 Dec 22;205(13):3119-31
references: 19047440
references: J Immunol. 1991 Oct 15;147(8):2663-9
references: 1717570
references: J Immunol. 2005 Nov 15;175(10):6551-9
references: 16272309
references: Immunogenetics. 2011 Jun;63(6):325-35
references: 21305276
references: Nat Biotechnol. 1999 Jun;17(6):555-61
references: 10385319
references: PLoS One. 2011;6(10):e26494
references: 22039500
references: Trends Mol Med. 2005 Sep;11(9):412-20
references: 16103011
references: J Immunol. 2010 Oct 1;185(7):4189-98
references: 20810981
references: J Virol. 1994 Dec;68(12):8056-63
references: 7966595
references: Virology. 2008 Aug 15;378(1):105-17
references: 18579176
references: Curr Opin Immunol. 2009 Jun;21(3):308-13
references: 19520559
references: Nat Immunol. 2009 Jan;10(1):116-125
references: 19029902
references: J Exp Med. 1998 Dec 21;188(12):2205-13
references: 9858507
references: J Exp Med. 2006 Feb 20;203(2):413-24
references: 16461338
references: PLoS One. 2010 Jun 11;5(6):e11072
references: 20552033
references: J Exp Med. 1993 Jul 1;178(1):27-47
references: 8315383
references: Nat Rev Immunol. 2009 Oct;9(10):741-7
references: 19763148
references: Vaccine. 2008 Oct 23;26(45):5712-21
references: 18762226
references: J Immunol. 2009 Apr 15;182(8):4865-73
references: 19342665
references: J Immunol. 2009 Dec 15;183(12):7919-30
references: 19933869
references: J Immunol Methods. 2003 Mar 1;274(1-2):221-8
references: 12609547
references: J Med Virol. 1998 Oct;56(2):159-67
references: 9746073
references: J Immunol. 1991 Jan 1;146(1):307-15
references: 1701796
references: Nat Med. 2003 May;9(5):619-24
references: 12704385
references: Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13269-74
references: 11069291
references: Cancer Res. 2001 Oct 15;61(20):7577-84
references: 11606397
references: Immunology. 2009 Sep;128(1 Suppl):e718-27
references: 19740333
references: Infect Immun. 2002 Jan;70(1):79-85
references: 11748166
references: Clin Immunol. 2004 Mar;110(3):243-51
references: 15047202
references: J Immunol. 2010 Nov 1;185(9):5405-16
references: 20870934
references: J Immunol. 2001 Aug 1;167(3):1283-9
references: 11466344
references: Cell. 1993 Jul 16;74(1):197-203
references: 8334703